Credit Suisse’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-20,804
| Closed | -$87K | – | 3472 |
|
|
2019
Q3 | $87K | Sell |
20,804
-30,968
| -60% | -$130K | ﹤0.01% | 3308 |
|
|
2019
Q2 | $150K | Buy |
51,772
+33,171
| +178% | +$96.1K | ﹤0.01% | 3251 |
|
|
2019
Q1 | $27K | Buy |
+18,601
| New | +$27K | ﹤0.01% | 3337 |
|
|
2017
Q1 | – | Sell |
-28,931
| Closed | -$301K | – | 3420 |
|
|
2016
Q4 | $301K | Sell |
28,931
-3,093
| -10% | -$32.2K | ﹤0.01% | 3304 |
|
|
2016
Q3 | $398K | Buy |
32,024
+3,872
| +14% | +$48.1K | ﹤0.01% | 3204 |
|
|
2016
Q2 | $303K | Sell |
28,152
-24,179
| -46% | -$260K | ﹤0.01% | 3382 |
|
|
2016
Q1 | $578K | Buy |
52,331
+40,828
| +355% | +$451K | ﹤0.01% | 2854 |
|
|
2015
Q4 | $140K | Sell |
11,503
-2,480
| -18% | -$30.2K | ﹤0.01% | 3783 |
|
|
2015
Q3 | $228K | Sell |
13,983
-25,501
| -65% | -$416K | ﹤0.01% | 3648 |
|
|
2015
Q2 | $836K | Buy |
39,484
+9,251
| +31% | +$196K | ﹤0.01% | 3082 |
|
|
2015
Q1 | $543K | Sell |
30,233
-9,471
| -24% | -$170K | ﹤0.01% | 3231 |
|
|
2014
Q4 | $681K | Buy |
39,704
+24,491
| +161% | +$420K | ﹤0.01% | 3124 |
|
|
2014
Q3 | $218K | Buy |
15,213
+769
| +5% | +$11K | ﹤0.01% | 3699 |
|
|
2014
Q2 | $217K | Buy |
+14,444
| New | +$217K | ﹤0.01% | 3874 |
|